Treatment of Immune Checkpoint Inhibitor-Induced Hypophysitis — Grade 4 (Severe or Life-Threatening)
Clinical Scenario
Grade 4 — Severe / Life-Threatening
This protocol addresses immune checkpoint inhibitor-induced hypophysitis (ICIHy) presenting at grade 4 severity — a severe or life-threatening complication of immune checkpoint inhibitor (ICI) therapy requiring urgent, structured management.
Treatment Approach
Management at this severity grade begins with a critical decision regarding the causative agent. The full protocol specifies the sequence of interventions, including the role of a particular class of systemic therapy in acute presentations.
Complete regimen details — including indications, sequence, and clinical decision points — are available in the full structured protocol.
References
DOI: 10.1016/j.beem.2019.101371
- For grade 4 (severe or life-threatening) ICIHy, ICI therapy must be discontinued and high dose glucocorticoid therapy must be administered.
- Nevertheless, high dose glucocorticoids are not recommended for ICIHy except for acute presentations such as symptomatic mass effects.
View source ↗